Skip to main content
Table of Contents
Print

What upcoming studies are focusing on cannabis and fibromyalgia? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

With growing interest in medical cannabis, more researchers are now investigating its role in treating fibromyalgia. Although past findings have been mixed, cannabis research continues to evolve, offering fresh hope for those living with chronic pain. 

Several fibromyalgia studies are currently underway, exploring how cannabinoids interact with the body’s pain and immune systems. This wave of ongoing research seeks to address unanswered questions around safety, effectiveness, and long-term impact. 

Key focus areas in upcoming cannabis research 

Here are the central themes emerging in upcoming studies: 

Pain modulation 

Researchers are exploring how THC and CBD influence fibromyalgia-related pain, focusing on nerve signalling and inflammation reduction. 

Strain-specific benefits 

Studies are examining whether certain cannabis strains are more beneficial for fibromyalgia, including their CBD to THC ratios and terpene profiles. 

Delivery method analysis 

Upcoming trials are comparing administration methods such as vaping, oils or oral capsules to measure differences in absorption and effectiveness. 

Long-term usage outcomes 

New fibromyalgia studies are also investigating how sustained cannabis use affects sleep, mood and daily functioning over months or years. 

Symptom-specific impact 

Scientists are assessing how cannabis affects individual symptoms such as fatigue, sleep disturbances and muscle stiffness. 

Regulatory and dosage insights 

As part of ongoing research, researchers are analysing the role of medical supervision, ideal dosing strategies, and potential side effects. 

As these findings unfold, they will shape future cannabis research and inform safer, more personalised treatments for fibromyalgia. 

If you’re exploring cannabis treatment options for fibromyalgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Fibromyalgia. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories